Onesource Specialty Pharma Ltd.
NSE: ONESOURCE | BSE: 544292
₹1,737.80
₹-51.90
(-2.90%)
As on 08-Jun-2026IST
Market cap
₹19,927 Cr
Revenue (TTM)
₹1,422 Cr
P/E Ratio
--
P/B Ratio
3.4
Div. Yield
0 %
Quality Score
1/10
Growth Score
3/10
Valuation Score
2/10
Momentum Score
7/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-74 Cr
-
ROE
-0.6 %
-
ROCE
2.6 %
-
Industry P/E
44.87
-
EV/EBITDA
66.1
-
Debt to Equity
0.1
-
Book Value
₹508.7
-
EPS
₹-5.8
-
Face value
1
-
Shares outstanding
114,645,801
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Onesource Specialty Pharma
| -4.0 | -4.3 | 17.4 | -10.2 | -- | -- | -- |
|
BSE Healthcare
| 7.8 | 0.9 | 7.5 | 8.3 | 24.2 | 13.6 | 12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Onesource Specialty Pharma
|
1,737.8 | 19,927.2 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.4 |
| 3,316.2 | 27,112.9 | 1,339.4 | 356.4 | 33.2 | 23.2 | 76.1 | 16.4 | |
| 424.3 | 16,226.6 | 2,268.6 | 150.1 | 10.6 | 5.4 | 90.5 | 4.1 | |
| 766.4 | 19,006.0 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.9 | 3.7 | |
| 957.4 | 15,162.8 | 8,279.6 | 397.8 | 9.9 | 6.4 | 38 | 2.1 | |
| 868.3 | 15,557.5 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 11 | 1.7 | |
| 165.3 | 22,020.5 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.7 | |
| 1,181.4 | 19,496.2 | 1,284.3 | 134.4 | -- | 30.7 | 79 | 15.1 | |
| 449.5 | 18,132.8 | 3,738.7 | 316.7 | 12.5 | 7.5 | 57.3 | 3.7 | |
| 1,892.9 | 30,770.3 | 3,373.0 | 199.0 | 12.6 | 5.9 | 144.5 | 6.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Onesource Specialty Pharma
OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and... internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors; sterile injectables; soft gelatin capsules; and biologics solutions for microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and RNA products. The company was formerly known as Stelis Biopharma Limited and changed its name to OneSource Specialty Pharma Limited in February 2024. OneSource Specialty Pharma Limited was incorporated in 2007 and is based in Bengaluru, India. Read more
-
Incorporated
2007
-
Chairman
Arun Kumar
-
Managing Director
Neeraj Sharma
-
Headquarters
Navi Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Onesource Specialty Pharma
What is the current share price of Onesource Specialty Pharma Ltd Today?
The share price of Onesource Specialty Pharma Ltd is ₹1,737.80 (NSE) and ₹1,738.15 (BSE) as of 08-Jun-2026 IST. Onesource Specialty Pharma Ltd has given a return of -10.16% in the last 1 years.
What is the current PB & PE ratio of Onesource Specialty Pharma Ltd?
Since, TTM earnings of Onesource Specialty Pharma Ltd is negative, P/E ratio is not available.
The P/B ratio of Onesource Specialty Pharma Ltd is 3.42 times as on 08-Jun-2026, a 17 discount to its peers’ median range of 4.10 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
3.41
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2025
|
0.00
|
3.41
|
What is the 52 Week High and Low of Onesource Specialty Pharma Ltd?
The 52-week high and low of Onesource Specialty Pharma Ltd are Rs 2,248.00 and Rs 1,057.00 as of 08-Jun-2026.
What is the market cap of Onesource Specialty Pharma Ltd?
Onesource Specialty Pharma Ltd has a market capitalisation of ₹ 19,927 Cr as on 08-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Onesource Specialty Pharma Ltd?
Before investing in Onesource Specialty Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.